2m 2m 2m 2m 2m 2m 2m
LANTERN PHARMA (LTRN)
NASDAQ
$0.65+$0.008 (+1.30%)
Price as of Oct 22, 2026 5:20 PM EDT- $10.2MMarket Cap
- -82.68%1-Year Change
- BiotechnologyIndustry
LANTERN PHARMA (LTRN)
$0.65+$0.008 (+1.30%)
LTRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.64 | ||
Change | -$0.04 (-6.40%) | ||
Open | $0.68 | ||
High | $0.71 | ||
Low | $0.64 | ||
Previous Close | $0.68 | ||
Volume | 109,509 | ||
30-Day Average Volume | 364,535 | ||
1-Week Change | -3.91% | ||
1-Month Change | -52.89% | ||
1-Year Change | -82.68% | ||
3-Year Change | -76.62% | ||
5-Year Change | -93.64% | ||
Fundamentals | |||
Shares Outstanding | 14.9M | ||
Total Assets | $8.6M | ||
Market Cap | $10.2M | ||
Enterprise Value | $3.6M | ||
Period: QTR TTM FY | |||
Revenue | $27,238.00 | ||
Net Income | -$7.1M | ||
Free Cash Flow | -$2.9M | ||
EBIT | -$7.1M | ||
EBITDA | -$7.1M | ||
Net Working Capital | $4.1M | ||
EPS | -$0.57 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 131 | ||
P/B | N/A | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue